BAJAJHCARE331.50

Bajaj Healthcare Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersTHEMISMEDLINCOLNWANBURYSIGACHIAHCLANUHPHRAMRUTANJANMcap ₹1,116 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations473.4542.6611.0627.8
Other Income8.719.47.17.1
Total Income482.1562.0618.2634.9
Expenses
+ Cost of Materials Consumed264.4307.1306.2327.9
+ Changes in Inventories-9.7-20.710.2-6.0
+ Employee Benefit Expense43.857.162.865.9
+ Finance Costs29.727.922.223.1
+ Depreciation & Amortisation27.627.927.528.9
+ Other Expenses98.5116.7127.1131.0
Total Expenses454.5516.0556.0570.8
EBITDA76.382.4104.8109.1
EBIT48.654.577.380.1
Profit
PBT before Exceptional Items27.746.062.264.1
+ Exceptional Items-44.30.0-33.2-33.2
Pretax Income-16.746.028.930.9
+ Deferred Tax-2.33.17.67.8
Tax Expense-2.33.17.67.8
Net Income-83.839.515.817.6
+ Net Income — Continuing Ops-14.342.921.323.0
+ Net Income — Discontinued Ops-69.5-3.4-5.5-5.4
+ Other Comprehensive Income-2.81.40.60.6
Total Comprehensive Income-86.640.916.418.3
Per Share
Basic EPS-30.3613.294.985.40
Diluted EPS-30.3613.124.975.25
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax-87.2-4.0-5.1-4.9
+ Tax — Discontinued Operations-17.7-0.60.40.5
Other Comprehensive Income — detail
+ Other Comprehensive Income1.40.60.6
+ Items NOT to be Reclassified to P&L-3.71.80.80.9
+ Tax on Items NOT to be Reclassified0.50.20.2
+ Tax on Items NOT to be Reclassified — alt tag-0.9
Per Share — as-filed variants
Basic EPS — Continuing Operations-5.1914.456.737.10
Diluted EPS — Continuing Operations-5.1914.266.726.94
Basic EPS — Discontinued Operations-25.17-1.16-1.75-1.70
Diluted EPS — Discontinued Operations-25.17-1.14-1.75-1.69
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit218.6256.2294.6305.9
Gross Margin %46.1847.2148.2248.73
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)27.746.062.264.1
− Exceptional Items (reconciliation)-44.30.0-33.2-33.2
Net Income Adj (tax-effected)-45.739.540.342.4
EPS Adj-16.5613.2912.7213.00
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value5.005.005.005.00
Filed Debt Equity0.000.440.46
Filed Dscr0.002.152.47
Filed Iscr0.043.803.70
Paid Up Equity Capital13.815.816.816.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.